Pascale Mauran appointed as new Vaccines Europe Vice-President

2016 02 02 Written by Vaccines Europe

Vaccines Europe is pleased to announce that Pascale Mauran, Vice-President for EU Vaccines Commercial Development at Pfizer, has been officially appointed as the new Vaccines Europe Vice-President. Pascale Mauran has been representing Pfizer on the Vaccines Europe Board for three years now and brings solid experience and expertise on vaccines to help driving the development of the Vaccines Europe for a life-long vaccination strategy in Europe. Pascale Mauran’s appointment as Vice-President will start immediately and is expected to run for two years. Vaccines Europe President Andrea Rappagliosi earlier stated “I am pleased to have Pascale Mauran joining the Executive team of the Vaccines Europe Board. Pascale brings great understanding of the challenges we are facing in Europe today. Her expertise and knowledge will be invaluable to help foster improved access to immunisation for all, and across the entire life course”.

Pascale Mauran stated: “I am looking forward to taking up this new challenge and express my thankfulness for the trust put on me by the Board. Working closely with the Vaccines Europe President and Executive Director will allow us to continue building on ongoing efforts to foster an environment that can help our industry thrive so we can continue delivering important life-saving vaccines for Europe and the world”.

For more information, please contact

Magdalena R. de Azero, Executive Director Vaccines Europe, magdalena.deazero@vaccineseurope.eu